Mediplus has announced the release of new sizes of the POPY Mediplus has announced the release of new sizes of the POPY (Pelvic Organ Prolapse pessary) product range.
The company is introducing five additional sizes to complement its existing products, offering a more precise fit and enhanced treatment options for women suffering from pelvic organ prolapse.
The POPY pessary range has been expanded to better meet the diverse needs of women with pelvic organ prolapse (POP).
Recognising that one size does not fit all, the range now offers 11 sizes in both short and long stem versions, ensuring a more tailored and effective solution for a wider range of patients.
This expansion provides improved support and comfort, offering a practical and personalised approach to managing POP.
Emma Gray, Managing Director at Mediplus, said: “We are always striving to develop and improve our products in response to the needs of patients and clinicians alike.
“The addition of 5 new sizes to the POPY™ pessary range ensures a better fit for more women, allowing us to provide a more effective, comfortable, and tailored solution for managing pelvic organ prolapse.
“It is part of our ongoing commitment to innovation and patient-centric care.”
Manufactured in the UK, the POPY pessary has long been a trusted, pioneering product in the management of pelvic organ prolapse and procidentia.
Known as the world’s first silicone shelf pessary, it provides a conservative and cost-effective alternative to surgery by alleviating the symptoms of prolapse, offering a comfortable and non-invasive solution that improves patients’ quality of life.
The new sizes reflect Mediplus’ commitment to putting patients first and responding to clinician feedback to ensure that more women can benefit from this innovative solution.
Established in 1986, Mediplus is a family-owned business renowned for its dedication to quality and innovation.
The company’s products have earned two Queens Awards and multiple accolades for contributions to Critical Care and Pelvic Floor, and Urology. Mediplus’s devices are sold in over 40 countries worldwide.
